Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Paulson

Showing results (281-290 of 404) with videos related to

Pageof 41
Sort By:
Chembiochem : a European Journal of Chemical Biology|June 30, 2020
Efficient Chemoenzymatic Synthesis of N-Glycans with a β1,4-Galactosylated Bisecting GlcNAc MotifMichael Weiss, Dimitri Ott, Theodoros Karagiannis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2021
Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen ChallengeShiteng Duan, Britni M Arlian, Corwin M Nycholat, et al.
Journal of Virology|December 21, 2018
Flexibility <i>In Vitro</i> of Amino Acid 226 in the Receptor-Binding Site of an H9 Subtype Influenza A Virus and Its Effect <i>In Vivo</i> on Virus Replication, Tropism, and TransmissionAdebimpe O Obadan, Jefferson Santos, Lucas Ferreri, et al.
Journal of Virology|August 8, 1998
Molecular basis for the generation in pigs of influenza A viruses with pandemic potentialT Ito, J N Couceiro, S Kelm, et al.
The Journal of Experimental Medicine|December 30, 2009
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoBao Hoa Duong, Hua Tian, Takayuki Ota, et al.
The EMBO Journal|May 1, 1987
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodiesP S Daniels, S Jeffries, P Yates, et al.
Oncology Reports|October 11, 2002
Clinical significance of ST3Gal IV expression in human renal cell carcinomaSeiichi Saito, Shin-Ichi Yamashita, Mareyuki Endoh, et al.
Frontiers in Immunology|March 31, 2022
Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T <i>PTPN22</i> Variant for Immunotherapy in Endocrine AutoimmunityAndrea Arena, Eugenia Belcastro, Francesca Ceccacci, et al.
Nature|February 9, 1984
Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen typeL M Loomes, K Uemura, R A Childs, et al.
Molecular Cancer|May 26, 2010
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytesJennifer A Belisle, Sachi Horibata, Gubbels A A Jennifer, et al.
Pageof 41

Showing results (281-290 of 404) with videos related to

Sort By:
Pageof 41
Chembiochem : a European Journal of Chemical Biology|June 30, 2020
Efficient Chemoenzymatic Synthesis of N-Glycans with a β1,4-Galactosylated Bisecting GlcNAc MotifMichael Weiss, Dimitri Ott, Theodoros Karagiannis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2021
Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen ChallengeShiteng Duan, Britni M Arlian, Corwin M Nycholat, et al.
Journal of Virology|December 21, 2018
Flexibility <i>In Vitro</i> of Amino Acid 226 in the Receptor-Binding Site of an H9 Subtype Influenza A Virus and Its Effect <i>In Vivo</i> on Virus Replication, Tropism, and TransmissionAdebimpe O Obadan, Jefferson Santos, Lucas Ferreri, et al.
Journal of Virology|August 8, 1998
Molecular basis for the generation in pigs of influenza A viruses with pandemic potentialT Ito, J N Couceiro, S Kelm, et al.
The Journal of Experimental Medicine|December 30, 2009
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoBao Hoa Duong, Hua Tian, Takayuki Ota, et al.
The EMBO Journal|May 1, 1987
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodiesP S Daniels, S Jeffries, P Yates, et al.
Oncology Reports|October 11, 2002
Clinical significance of ST3Gal IV expression in human renal cell carcinomaSeiichi Saito, Shin-Ichi Yamashita, Mareyuki Endoh, et al.
Frontiers in Immunology|March 31, 2022
Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T <i>PTPN22</i> Variant for Immunotherapy in Endocrine AutoimmunityAndrea Arena, Eugenia Belcastro, Francesca Ceccacci, et al.
Nature|February 9, 1984
Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen typeL M Loomes, K Uemura, R A Childs, et al.
Molecular Cancer|May 26, 2010
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytesJennifer A Belisle, Sachi Horibata, Gubbels A A Jennifer, et al.
Pageof 41